Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last C$0.33 CAD
Change Today 0.00 / 0.00%
Volume 11.9K
GLG On Other Exchanges
As of 3:52 PM 06/29/15 All times are local (Market data is delayed by at least 15 minutes).

glg life tech corp (GLG) Snapshot

Previous Close
Day High
Day Low
52 Week High
01/8/15 - C$0.69
52 Week Low
09/15/14 - C$0.21
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for GLG LIFE TECH CORP (GLG)

Related News

No related news articles were found.

glg life tech corp (GLG) Related Businessweek News

No Related Businessweek News Found

glg life tech corp (GLG) Details

GLG Life Tech Corporation engages in the research and development, growing, refining, production, and distribution of stevia extract to the food and beverage industry in China and North America. Stevia extract is a natural sweetener extracted from the stevia plant. The company was formerly known as GLG Life Tech Limited and changed its name to GLG Life Tech Corporation in March 2007. GLG Life Tech Corporation was founded in 2005 and is headquartered in Vancouver, Canada.

293 Employees
Last Reported Date: 03/31/15
Founded in 2005

glg life tech corp (GLG) Top Compensated Officers

Chairman and Chief Executive Officer
Total Annual Compensation: --
President, Chief Financial Officer and Corpor...
Total Annual Compensation: C$250.0K
Vice President of Sales
Total Annual Compensation: C$120.0K
Compensation as of Fiscal Year 2014.

glg life tech corp (GLG) Key Developments

GLG Life Tech Corporation Reports Consolidated Earnings Results for the First Quarter Ended March 31, 2015

GLG Life Tech Corporation reported consolidated earnings results for the first quarter ended March 31, 2015. For the quarter, the company's revenue was CAD 6,168,000 compared to CAD 4,663,000 a year ago. This 32% increase in sales was attributable to a mix of stevia extracts, monk fruit extract and sales of other natural ingredient products. Loss from operations was CAD 2,179,000 compared to CAD 2,505,000 a year ago. Net loss before income taxes was CAD 4,765,000 compared to CAD 4,972,000 a year ago. Net loss was CAD 4,765,000 compared to CAD 4,972,000 a year ago. The decrease in net loss was driven by an increased gross profit of CAD 0.9 million, which was offset by an increase in G&A expense of CAD 0.6 million and an increase in other expenses of CAD 0.1 million. Basic & diluted loss per share was CAD 0.13 compared to CAD 0.15 a year ago. Loss per share from continuing operations was CAD 0.13 per share for the quarter ended March 31, 2015, compared to the prior year CAD 0.15 per share or a 13% improvement. LBITDA was CAD 553,000 compared to CAD 1,294,000 a year ago.

GLG Life Tech Corporation, Annual General Meeting, Jun 26, 2015

GLG Life Tech Corporation, Annual General Meeting, Jun 26, 2015., at 09:00 Pacific Standard Time. Location: Pan Pacific, 999 Canada Place. Agenda: To receive the report of the directors of the corporation; to receive the audited financial statements of the corporation for the financial year ended December 31, 2014, and accompanying report of the auditor; to appoint Davidson & Company, LLP as the auditor of the corporation for the ensuing year and to authorize the directors to fix the auditor's remuneration; to set the number of directors of the corporation at seven; to elect the directors of the corporation for the upcoming year; and to transact such other business as may properly come before the meeting.

GLG Life Tech Corporation Announces FDA’s Issuance of Letter of No Objection for its High-Purity Rebaudioside D Stevia Extract

GLG Life Tech Corporation announced that United States Food and Drug Administration has issued a Letter of No Objection for GLG’s high-purity Rebaudioside D stevia extract where used as a general purpose sweetener. (Filing No. GRN 548). GLG submitted its application pursuant to the FDA’s GRAS program, through which a company may submit its determination, along with supporting research and studies, that a particular ingredient is Generally Recognized As Safe. The FDA’s Letter of No Objection confirms that the FDA has no questions regarding GLG’s GRAS notice submitted earlier this year, in which GLG, through in-depth consultation with GRAS Associates, LLC, reported the results of its extensive studies and its conclusion that high-purity Rebaudioside D (> 95% purity) is Generally Recognized as Safe. High-purity Rebaudioside D stevia extracts have a sweetness level comparable to high-purity Rebaudioside A and have a superior taste profile to Rebaudioside A (less bitterness and astringency). Several major consumer brands have expressed interest in Rebaudioside D. To date, the supply availability and high price of Rebaudioside D extracts have been limiting factors for their broader use in the natural sweetener market. However, GLG is working on an agriculture R&D program to address both of these factors.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GLG:CN C$0.33 CAD 0.00

GLG Competitors

Market data is delayed at least 15 minutes.

Company Last Change
PureCircle Ltd 398.75 GBp -5.00
Redpoint Bio Corp $0.0030 USD 0.00
Senomyx Inc $4.96 USD -0.46
Stevia First Corp $0.20 USD -0.01
Sunwin Stevia International Inc $0.30 USD +0.001
View Industry Companies

Industry Analysis


Industry Average

Valuation GLG Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.6x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales NM Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GLG LIFE TECH CORP, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at